Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Testing effectiveness (Phase 2)Looking for participantsNCT06272214
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Who this might be right for
Adjuvant Radiotherapy
Zhejiang Cancer Hospital 146
Not applicableStudy completedNCT02810652
What this trial is testing

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Who this might be right for
Pancreatic CancerEsophageal CancerGastric Cancer+3 more
Massachusetts General Hospital 160
Not applicableUnknownNCT03587532
What this trial is testing

Assessment of Graft Perfusion and Oxygenation for Improved Outcome in Esophageal Cancer Surgery

Who this might be right for
Anastomotic LeakEsophageal Cancer
University Hospital, Ghent 70
Testing effectiveness (Phase 2)Study completedNCT01364493
What this trial is testing

Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 51
Early research (Phase 1)WithdrawnNCT02205463
What this trial is testing

KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer

Who this might be right for
Esophageal CancerStomach Cancer
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT00669292
What this trial is testing

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wakayama Medical University 29
Testing effectiveness (Phase 2)Looking for participantsNCT07795749
What this trial is testing

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Who this might be right for
Esophageal CarcinomaGastric Cancer (Diagnosis)Colorectal Adenocarcinoma+3 more
University of California, Irvine 55
Not applicableEnrolling By InvitationNCT06984055
What this trial is testing

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

Who this might be right for
Esophageal Cancer, Squamous Cell
Changhai Hospital 600
Not applicableNot Yet RecruitingNCT05890339
What this trial is testing

Laparoscopic Proximal Gastrectomy With Double-flap Technique Versus Laparoscopic Total Gastrectomy With Roux-en-Y Reconstruction for Proximal Early Gastric Cancer

Who this might be right for
Stomach Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 216
Not applicableStudy completedNCT01858805
What this trial is testing

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer

Who this might be right for
Resectable Esophageal Cancer
Universitätsklinikum Hamburg-Eppendorf 123
Not applicableStudy completedNCT04649372
What this trial is testing

EndoVE endosCopic Treatment for Oesophageal and Gastric canceR

Who this might be right for
Oesophageal CancerOesophageal DiseaseGastric Cancer
Mirai Medical 30
Testing effectiveness (Phase 2)Study completedNCT00063986
What this trial is testing

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Eastern Cooperative Oncology Group 110
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Testing effectiveness (Phase 2)WithdrawnNCT03982173
What this trial is testing

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Colorectal CancerTriple Negative Breast CancerProstate Adenocarcinoma+2 more
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Study completedNCT03292757
What this trial is testing

FLOTOR Pilot Study

Who this might be right for
ChylothoraxEsophageal CancerThoracic Duct Intra-Operative Injury
Oxford University Hospitals NHS Trust 21
Not applicableStudy completedNCT04862637
What this trial is testing

Detecting the Changes of Swallowing Function in Oral Cancer Patients

Who this might be right for
Swallowing Function
National Taiwan University Hospital 48
Not applicableWithdrawnNCT02657850
What this trial is testing

Head and Neck Cancer Treatment Related Dysphagia

Who this might be right for
Head and Neck CancerDysphagia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableUnknownNCT06036563
What this trial is testing

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

Who this might be right for
Cancer DiagnosisLungCancerGastric Cancer+5 more
Air Force Military Medical University, China 3,200
Testing effectiveness (Phase 2)Looking for participantsNCT07733830
What this trial is testing

Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Next Page